Skip to main content
Clinical Trials/JPRN-UMIN000027070
JPRN-UMIN000027070
Completed
未知

Clinical trial of immunomodulatory therapy using anti-thymocyte globulin and pegfilgrastim for recently onset type 1 diabetes - Immunomodulatory therapy using ATG/PeG-CSF for recently onset type 1 diabetes

Toyama University0 sites12 target enrollmentApril 21, 2017
ConditionsType 1 diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 1 diabetes
Sponsor
Toyama University
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 21, 2017
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Toyama University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Active infection 2\. Pregnancy/breast\-feeding 3\. Past history of malignant tumor 4\. Interstitial pneumonia 5\. Severe liver or/and kidney dysfunction 6\. Past history of ATG administration 7\. Under systemic steroid therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials